science
FDA Advisory Committee Schedules July 2026 Review of Compounding Pharmacies' Peptide Production
An FDA advisory committee is scheduled to evaluate authorizing compounding pharmacies to produce certain injectable peptides in July 2026. This follows a March 2026 public meeting where peptide inclusion in oral dietary supplements was discussed. The moves come amid ongoing debates over peptide safety and regulation.
fda.govAudio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.
An FDA advisory committee is set to consider in July 2026 whether compounding pharmacies should be authorized to produce certain injectable peptides, Science News reported. The FDA under the former Biden administration had directed compounding pharmacies to stop making certain peptides due to safety concerns, including the possibility of immune reactions.
Compounding pharmacies make drugs that are not commercially available or are in short supply.
In March 2026, the FDA held a public meeting to discuss the scope of ingredients allowed in oral dietary supplements. At that meeting, peptide proponents advocated for the inclusion of peptides in oral dietary supplements. FDA Deputy Commissioner for Food Kyle Diamantas said at the March 2026 meeting that the administration’s goals include cutting out red tape.
Dietary supplements can include ingredients such as vitamins, minerals, and herbs that can be sold on promises to support general health and wellness as long as they don’t claim to treat specific conditions. Supplements do not have to go through rigorous studies to prove safety and efficacy before hitting store shelves.
Peptide therapies are promoted for treating ailments including joint pain, brain fog, and insomnia.
U.S. Food and Drug Administration. Many peptide products have hardly been studied in people. Some people buy peptides from online retailers or overseas suppliers and inject them at home.
Some doctors write prescriptions that allow people to buy certain peptides from compounding pharmacies. Many people purchase peptides unprescribed from direct-to-consumer websites or overseas factories. Some peptides purchased from direct-to-consumer websites or overseas factories are technically intended for research not human consumption.
